If the attending pops their head in the room and chats with the patient or writes a prescription, we will code higher, but it is dependent on the intervention of the attending not the intensity of the visit from my perspective. The attending co-signs all notes whether or not they actually saw the patient. I think that just about covers it. Let me know how things work out. I am presently evaluating billing according to time spent with pt.
Any questions just email back.
We are also involved in other drug therapies but only on occasion. We also keep in mind that our main objective is to support education for the medical residents. Another practice is to be involved in joint visits with the residents. In the State of Washington, pharmacists are allowed by legislation to initiate, modify and monitor drug therapy under written protocols since 1982. This setting of dependent authority to provide collaborative drug therapy works well in residency clinics.